Scroll to Top
/ Press Releases & Statements
Press Releases & Statements
EFPIA welcomes Commission decision for a policy strategy agenda to strengthen the competitiveness of the pharmaceutical industry
11 October 2012
Need for concrete measures at national level to help stimulate innovation and ensure access for all European patients to modern ...
Stem cells discovery gets Nobel Prize
09 October 2012
11.10.2012, Brussels: EFPIA would like to congratulate Sir John Gurdon and Shinya Yamanaka for winning this year’s Nobel Prize of medicine for their work on the ...
Interpol crackdown on illicit online pharmacies
08 October 2012
11.10.2012, Brussels: Interpol last week announced the seizure of over 3.75million units of counterfeit medicines worth over 10million USD. Operation Pangea V - the largest internet ...
Launch of online resource for challenging drug patents by MSF
05 October 2012
On Tuesday 2nd October MSF launched an online resource to help civil society groups and patient groups in developing countries to challenge unwarranted drug patents through patent ...
Global pharmaceutical industry calls for broad-based cooperation to fight online sales of counterfeit medicines around the world
24 July 2012
Four major pharmaceutical associations issue joint policy statement to crack down on counterfeits from illicit Internet pharmacies and other sources Statement comes as the U.S. launches ...
"Reform of EU Clinical Trials Rules - Europe can’t afford to fail!", says Richard Bergström.
17 July 2012
EFPIA welcomes the proposal for a new Regulation on Clinical Trials on Medicinal Products for Human Use adopted today by the European Commission as a ...
President of EFPIA calls for pharma innovation to be a key part of a European growth strategy
27 June 2012
Brussels, 27 June 2012: Sir Andrew Witty, CEO of GlaxoSmithKline and President of EFPIA, the body representing the research-based pharmaceutical industry in Europe, called today ...
EU Pharmaceutical industry leaders call for revision of German model for assessment of new medicines
08 June 2012
In today's meeting in Berlin the leading pharmaceutical companies of Europe, represented in EFPIA, asked the German Government for urgent action to protect patient access ...
World Anti-Counterfeiting Day 2012: ESM Progress in seeking to protect European Patients from Counterfeit Medicines
07 June 2012
On the occasion of World Anti-Counterfeiting Day, EAEPC, EFPIA, GIRP and PGEU are pleased to announce significant progress on their proposed European Stakeholder Model (ESM), ...
EFPIA contributes to IMI €223,7 million programme to tackle Antibiotic resistance
24 May 2012
EFPIA, the voice of the research-based pharmaceutical industry in Europe, welcomes the launch today by the Innovative Medicines Initiative (IMI) public-private partnership, a €223,7 million ...
Page 19 of 20
Press Releases & Statements
Enabling Technologies for Better Patient Outcomes - Live Streaming
Facts & Figures
Follow us on
Add us on
Check us out on
EFPIA Brussels Office
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
European Biopharmaceutical Enterprises
INNOVATIVE MEDICINES INITIATIVE
Educational Events & Ethical Evaluation
EFPIA 2017 - All rights reserved -
- Design by
Morris & Chapman